Cerebras Systems Inc.

The stock is in a post-IPO reset, still well below its 200-day average after a sharp run from the 52-week low. The longer-term setup remains volatile and speculative, with the shares trading far under the 52-week high and trying to stabilize after a steep de-rating.

Street coverage is constructive, with a Buy consensus and a target cluster around $297 to $300. Recent action has been mostly reaffirmations and target raises, including UBS to $320 and Wedbush to $280, which signals continued confidence even after the stock’s pullback.

The next print is set against a mixed but improving backdrop: the company beat by 71.4% on the last reported quarter, while the upcoming quarter is estimated at a smaller loss than the prior period. Shareholders should watch revenue ramp, margin discipline, and whether losses narrow toward the 2027 profit path.

Recent insider activity leans clearly to net selling, led by multiple COO sales and a cluster of director and CEO-related transactions. Several conversion entries also appear, but the discretionary sales dominate the signal and suggest insiders have been taking liquidity after the IPO.

Growth is strong but profitability is still uneven. Revenue grew 94.4% year over year, gross margin was 40.3%, and operating margin remained negative at -7.78%, showing the business is scaling faster than it is converting that scale into operating profit.

CBRS stands out on AI infrastructure differentiation, using wafer-scale compute rather than a conventional GPU architecture. Versus semiconductor peers, the valuation is still rich and the market is pricing in a steep growth curve, with the target range implying substantial upside if execution holds.